AstraZeneca
AZN
#47
Rank
HK$2.176 T
Marketcap
HK$702.00
Share price
0.17%
Change (1 day)
35.12%
Change (1 year)

AstraZeneca (AZN) - Cash on Hand

Cash on Hand as of September 2025 : HK$63.69 Billion

According to AstraZeneca's latest financial reports the company has HK$63.69 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

AstraZeneca - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$42.89 B-6.28%
2023-12-31HK$45.76 B-6.17%
2022-12-31HK$48.77 B-2.23%
2021-12-31HK$49.88 B-19.48%
2020-12-31HK$61.95 B27.96%
2019-12-31HK$48.41 B10.53%
2018-12-31HK$43.80 B23.12%
2017-12-31HK$35.58 B-21.04%
2016-12-31HK$45.06 B-13.78%
2015-12-31HK$52.26 B-4.3%
2014-12-31HK$54.61 B-28.82%
2013-12-31HK$76.72 B20.37%
2012-12-31HK$63.73 B-27.22%
2011-12-31HK$87.57 B-4.83%
2010-12-31HK$92.02 B4.09%
2009-12-31HK$88.40 B160.55%
2008-12-31HK$33.93 B-26.96%
2007-12-31HK$46.45 B-22.27%
2006-12-31HK$59.76 B54.81%
2005-12-31HK$38.60 B-5.65%
2004-12-31HK$40.91 B33.6%
2003-12-31HK$30.62 B-16.23%
2002-12-31HK$36.55 B22.64%
2001-12-31HK$29.81 B-14.16%
2000-12-31HK$34.72 B35.95%
1999-12-31HK$25.54 B-3.37%
1998-12-31HK$26.43 B183.06%
1997-12-31HK$9.33 B-27.69%
1996-12-31HK$12.91 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Bristol-Myers Squibb
BMY
HK$128.45 B 101.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$116.64 B 83.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$141.78 B 122.61%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$34.59 B-45.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
HK$81.36 B 27.74%๐Ÿ‡ซ๐Ÿ‡ท France
Eli Lilly
LLY
HK$77.17 B 21.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$144.49 B 126.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$60.19 B-5.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$30.82 B-51.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$75.92 B 19.20%๐Ÿ‡จ๐Ÿ‡ญ Switzerland